This Senior Principal Research Fellowship will support a program of translational research and leadership for the Therapeutics Research Centre that is based at the Translational Research Institute in Brisbane and The Basil Hetzel Institute in Adelaide and for future researchers/research leaders in clinical medicine. A key research focus will be in improving the safety and efficacy of products and nanosystems, especially after application to the skin and/or absorption into the body.
Development Of New Antibacterial Peptoids To Combat Antibiotic Resistant Bacteria
Funder
National Health and Medical Research Council
Funding Amount
$181,500.00
Summary
The recent emergence of super bug bacterial strains has posed a situation where infections can not be treated. This health problem is growing rapidly with the spread of the resistant bacteria. This proposal intends to develop some of our designed anti-bacterial drugs to the point where they may be incorporated into mass clinical trials. A successful result will yield both a new antibiotic as well as an antibiotic to treat the super bugs.
Improving Therapeutic Outcomes Through Pharmaceutical Sciences Research
Funder
National Health and Medical Research Council
Funding Amount
$823,008.00
Summary
This Fellowship seeks to improve patient outcomes by better understanding of how drugs and nanotechnology systems interact with the body under normal and diseased conditions, and to translate these findings into improved therapeutic and chemical safety practice. Aspects include how medicines are absorbed through skin; are handled in normal and diseased patients; are best administered, including to intensive care patients; and the development of new clinical pharmacy practitioner - researchers.